|
Story |
Defined Contribution: Magic Bullet? |
webadmin |
|
Story |
Going on the Offensive Against Defensive Medicine |
webadmin |
|
Story |
Insurers Need to Ensure IT Readiness for ICD-10 |
webadmin |
|
Story |
Control Specialty Drug Cost By Making Your PBM Helpful |
webadmin |
|
Story |
Primary care continues to feel the strain |
webadmin |
|
Blog entry |
The Death of Disease Management (Finally) |
Archelle Georgiou MD |
|
Story |
Health Coverage Lessons From the Greek Meltdown |
webadmin |
|
Story |
Flat Tax? Single Payer? Find Those Easy Answers |
webadmin |
|
Story |
The Dawning of the Age of Accountability |
webadmin |
|
Story |
A Conversation with Donald R. Fischer, MD, MBA: Taking Charge in an Era of Change |
webadmin |
|
Story |
Managed care's influence felt on brand-name drugs |
webadmin |
|
Story |
Is Care Coordination Making Carve-outs Less Desirable? |
webadmin |
|
Story |
Transgenic Goats Are Key To Antithrombin Production |
webadmin |
|
Story |
Health Plans Undaunted By Medicare Part D |
webadmin |
|
Story |
Cancer costs to reach at least $173B in 2020 |
webadmin |
|
Story |
Part D plans embrace specialty drug tiers |
webadmin |
|
Story |
Safeguards Against Stockpiling Now Have Global Ramifications |
webadmin |
|
Story |
It's To Plans' Benefit To Spell Out Authority |
webadmin |
|
Story |
Bed days higher in smaller markets? Not with commercial plans |
webadmin |
|
Story |
DM Vendors Start To Address Costs Created by Comorbidities |
webadmin |
|
Story |
OTC Status for Low-Dose Lovastatin Would Have Widespread Implications |
webadmin |
|
Story |
Hypertension: New guidelines, still costly |
webadmin |
|
Story |
Health care systems turn to bonus pay |
webadmin |
|
Story |
Headlines On Deadline... |
webadmin |
|
Story |
Linx Technology Avoids Heart Valve Complication |
webadmin |
